The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a

被引:53
|
作者
Lv, Li [1 ]
Jia, Jian-Qin [1 ]
Chen, Jin [2 ]
机构
[1] Tianjin Hosp, Dept Dermatol, 406 Liberat South Rd, Tianjin 300211, Peoples R China
[2] Publ Secur Hosp, Dept Dermatol, Tianjin, Peoples R China
关键词
Melanoma; CCAT1; miR-33a; Competing endogenous RNA (ceRNA); LONG NONCODING RNA; TUMOR-SUPPRESSOR; EPIDEMIOLOGY; PROGRESSION; MANAGEMENT; DIAGNOSIS; BIOMARKER; SURVIVAL; CANCER; ACTS;
D O I
10.3727/096504017X14920318811749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is increasingly evident that various long noncoding RNAs (lncRNAs) participate in the tumorigenesis of multiple tumors, including melanoma. lncRNAs have been validated as oncogenic factors in various tumors; however, the potential regulatory mechanism of CCAT1 in melanoma is still unclear. The purpose of this study was to investigate the regulation of CCAT1 on melanoma genesis. The expression of CCAT1 in melanoma tissue and cell lines was measured using qRT-PCR. Interference oligonucleotide or mimic sequences were applied to up- or downregulate RNA expression. CCK-8 and colony formation assays were performed to detect the proliferation capability. Transwell assay was used to assess the migration and invasion capacities. Bioinformatics analysis was performed to predict the target miRNAs of CCAT1. Expression of CCAT1 was significantly upregulated in melanoma tissue and cell lines. CCA:11 knockdown observably suppressed the proliferation, migration, and invasion abilities. Bioinformatics analysis predicted that miR-33a acted as a target of CCAT1, which was confirmed by dual-luciferase reporter assay. CCAT1 knockdown reversed the tumor-promoting ability of the miR-33a inhibitor. CCAT1 acts as an oncogenic factor in the genesis of melanoma and exerts tumor-promoting roles via sponging miR-33a, providing a novel insight for competing endogenous RNA (ceRNA) in the tumorigenesis of melanoma.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [41] Knockdown of lncRNA CCAT1 Inhibits the Progression of Colorectal Cancer via hsa-miR-4679 Mediating the Downregulation of GNG10
    Wang, Ning
    Li, Jun
    He, Ju
    Jing, Yong-Guang
    Zhao, Wei-dong
    Yu, Wen-jin
    Wang, Jing
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [42] CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p
    Ma, Dan
    Cao, Yingying
    Wang, Zhenhua
    He, Jie
    Chen, Huimin
    Xiong, Hua
    Ren, Linlin
    Shen, Chaoqin
    Zhang, Xinyu
    Yan, Yuqing
    Yan, Tingting
    Guo, Fangfang
    Xuan, Baoqin
    Cui, Zhe
    Ye, Guangyao
    Fang, Jing-Yuan
    Chen, Haoyan
    Hong, Jie
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (05) : 862 - 874
  • [43] LncRNA CCAT2 promotes the proliferation and invasion of renal cell cancer by sponging miR-320a
    Wu, Guoyu
    Ke, Jianlong
    Wang, Jinyang
    Zhu, Xi
    Xiong, Shaoquan
    PANMINERVA MEDICA, 2022, 65 (03) : 436 - 437
  • [44] LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression
    Zhang, Hailin
    Bai, Ming
    Zeng, Ang
    Si, Loubin
    Yu, Nanze
    Wang, Xiaojun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (12): : 2526 - 2535
  • [45] The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a
    Chen, Qiaofeng
    Wang, Meiai
    Wu, Shanpeng
    CELL CYCLE, 2020, 19 (09) : 1059 - 1065
  • [46] Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
    Chun Yang
    Yong Pan
    Shao Ping Deng
    BMC Molecular and Cell Biology, 20
  • [47] Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
    Yang, Chun
    Pan, Yong
    Deng, Shao Ping
    BMC MOLECULAR AND CELL BIOLOGY, 2019, 20 (1)
  • [48] CRISPR/Cas9 Knockout Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells
    Khadijeh Zare
    Milad Shademan
    Mohammad M. Ghahramani Seno
    Hesam Dehghani
    Biological Procedures Online, 2018, 20
  • [49] Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer
    Liu, Feng
    Wang, Yutingzi
    Cao, Yang
    Wu, Zhiwei
    Ma, De
    Cai, Jun
    Sha, Jie
    Chen, Qing
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 374
  • [50] CRISPR/Cas9 Knockout Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells
    Zare, Khadijeh
    Shademan, Milad
    Seno, Mohammad M. Ghahramani
    Dehghani, Hesam
    BIOLOGICAL PROCEDURES ONLINE, 2018, 20